研究论文
The enhanced pathological response from additional immunotherapy improved recurrence-free survival for esophageal squamous cell carcinoma: a multi-center cohort study
Shuhan Xie, Hui Xu, Jinxin Xu, Zi-Lu Tang, Shijie Huang, Jinbiao Xie, Rongyu Xu, Sunkui Ke 等 10 位
Fujian Medical University Union Hospital Zhongshan Hospital of Xiamen University Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
210
226
关键指标
2
被引次数 · OpenAlex
2.01
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 13%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
37
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Esophageal Cancer Research and Treatment
Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses
参考文献 37
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
被引 1,457Nobutoshi Ando, Hoichi Kato, Hiroyasu Igaki · Annals of Surgical Oncology · 2011
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
被引 5,565Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot · New England Journal of Medicine · 2012
Chemotherapy-Induced Immunomodulation in Non-Small-Cell Lung Cancer: A Rationale for Combination Chemoimmunotherapy
被引 55Hua Zheng, Masha Zeltsman, Marjorie G. Zauderer · Immunotherapy · 2017
此处列出前 3 条
引用本文 2
A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma
被引 1Aizemaiti Rusidanmu, Kun Zhou, Xingxin Zhu · Annals of Surgical Oncology · 2026
Effectiveness comparison of pembrolizumab versus other immune checkpoint inhibitors in neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma
被引 0Mingduan Chen, Shuhan Xie, Zhinuan Hong · Frontiers in Cell and Developmental Biology · 2026
按被引量排序，此处列出前 3 条